Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
BusinessUS government moves to block J&J talc bankruptcy resolution
Firm’s third attempt to shift claims to a subsidiary had gained significant support
-
BusinessSanofi spins out its consumer healthcare business
US-based investment firm takes controlling stake in Opella, while France’s government moves to ensure the company remains in the country
-
BusinessDrug companies reluctantly accept state price negotiations
As legal challenges fall flat, will industry’s claims of stifled innovation be borne out?
-
BusinessUS approves schizophrenia drug with new mode of action
Cobenfy promises to better address negative symptoms than existing antipsychotics
-
WebinarThe science and promise of liquid biopsies
Join us on 4 December to learn more about the science of liquid biopsies from leaders in the field
-
OpinionA chemist in the flower garden
The beautifully complex molecules plants produce are as inspiring as the blooms themselves
-
WebinarCopper-catalysed carbon-heteroatom bond-forming processes
Explore cutting edge copper-catalysed carbon-heteroatom bond formations used in industrial applications
-
BusinessUS industry braced for change as election looms
Regulation, trade tariffs and innovation support top lists of concerns
-
ArticleDriving innovation in the UK’s emerging biotechnology sector
Biotech startups and spinouts must overcome numerous challenges to get from lab to market. A new UK innovation hub aims to give this emerging sector the space, resources and expertise it needs.
-
BusinessLatest effort to crack down on combination drugs launched by Indian government
Several pharmaceutical firms have launched a challenge to the ban in the supreme court
-
OpinionBeing wrong is almost inevitable
On the tightrope of expressing your opinion, you always risk looking a fool
-
OpinionGLP-1 drugs could be more than a win–win for weight loss
Semaglutide and tirzepatide are changing lives, and could change our attitudes
-
FeatureThe GLP-1 weight loss revolution
Glucagon-like peptide-1 agonist drugs, such as semaglutide, could save countless lives at risk due to diabetes and obesity. Rachel Brazil looks at the difficulties in making the peptides themselves, and what’s coming next
-
Business17 dead in solvent explosion at Indian plant
Dozens more injured at pharmaceutical ingredients manufacturer in Andhra Pradesh
-
BusinessMDMA rejection poses questions for psychedelic drug trials
Decision prompts reflection over how psychotherapy is involved, regulating combination treatments and safeguarding patients
-
WebinarAI meets chemistry: Standigm’s breakthrough with Synthia Retrosynthesis Software
Discover how Standigm’s use of Synthia can accelerate AI-driven drug discovery
-
OpinionMedicinal chemistry’s biological blind spots
Despite advances in modern medicine, there are some big gaps in our knowledge
-
BusinessExplainer: Why drug shortages happen and how can we reduce them?
Record-high numbers of drugs are in short supply, from chemotherapy and antibiotics to hormone replacements
-
OpinionWorking in the chemical industries, plural
Despite often being presented as a monolith, there’s a huge variety of activities, working practices and reaction scales across industrial research
-
ResearchTherapeutic proteins can hitch a ride on parasite to bypass blood-brain barrier
Toxoplasma could be delivery agent for protein drugs – provided parasite can be made safe